Cargando…

93. Enhanced Oral Care as Prevention for Non-ventilator Hospital Acquired Pneumonia

BACKGROUND: Non ventilator hospital-acquired pneumonia (NVHAP) is now the most common HAI. The purpose was to test primary source control through reduction of germs in the mouth as a modifiable risk factor for in NVHAP prevention. METHODS: The 12-month study (10/1/18–9/31/19) was conducted at an 800...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giuliano, Karen K, Penoyer, Daleen, Middleton, Aurea, Baker, Dian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777851/ http://dx.doi.org/10.1093/ofid/ofaa439.403

Ejemplares similares

1477. Impact Of Resistance Thresholds On Mortality In Hospital-Acquired And Ventilator-Associated Pneumonia
por: Mazi, Patrick B, et al.
Publicado: (2020)

Intravenous Smart Pumps During Actual Clinical Use: A Descriptive Comparison of Primary and Secondary Infusion Practices
por: Giuliano, Karen K., et al.
Publicado: (2021)

Patient safety and quality care: Time to focus on nonventilator hospital-acquired pneumonia
por: Giuliano, Karen, et al.
Publicado: (2022)

Prevention practices for nonventilator hospital-acquired pneumonia: A survey of the Society for Healthcare Epidemiology of America (SHEA) Research Network (SRN)
por: Baker, Dian L., et al.
Publicado: (2022)

382. Incidence of Hospital-Acquired and Ventilator-Associated Pneumonia in Patients with Severe COVID 19 on High Flow Oxygen
por: Papamanoli, Aikaterini, et al.
Publicado: (2020)

1476. Objective Surveillance Definitions for Hospital-Acquired Pneumonia in Non-Ventilated Patients
por: Ji, Wenjing, et al.
Publicado: (2018)

Implementation of a ventilator care bundle to reduce the incidence of ventilator acquired pneumonia
por: Mandal, AK, et al.
Publicado: (2011)

Does improved oral hygiene alone prevent ventilator-associated pneumonia?
por: Bleakley, S, et al.
Publicado: (2009)

Gastroesophageal reflux in mechanically ventilated pediatric patients and its relation to ventilator acquired pneumonia
por: Shahin, T, et al.
Publicado: (2009)

The current pathogens and treatment of hospital-acquired pneumonia/ventilator-associated pneumonia in medical intensive care units
por: Chang, Y, et al.
Publicado: (2015)

Effect of an oral care protocol in preventing ventilator-associated pneumonia in ICU patients
por: Yao, L, et al.
Publicado: (2008)

A Cool Drink on a Hot Day – Hospital-Acquired Legionella Pneumonia
por: Krystofiak, S.P.
Publicado: (2006)

2599. Impact of Alveolar Neutrophilia on Outcomes in Patients with Suspected Ventilated Hospital-Acquired Bacterial Pneumonia
por: Saravolatz, Louis, et al.
Publicado: (2023)

1460. Imipenem/Cilastatin (IMI)/Relebactam (REL) in Hospital-Acquired/Ventilator-Associated Bacterial Pneumonia (HABP/VABP): Subgroup Analyses of Critically Ill Patients in the RESTORE-IMI 2 Trial
por: Chen, Luke F, et al.
Publicado: (2020)

Prevention of ventilator-associated pneumonia in the surgical ICU at Siriraj Hospital
por: Pisitsak, CH, et al.
Publicado: (2013)

1472. Antibiotic De-escalation Compared with Continued Empirical Treatment in Non-Ventilated Hospital-Acquired Pneumonia
por: Alnaimi, Shaikha, et al.
Publicado: (2018)

1230. Clinical and Microbiologic Outcomes by Causative Pathogen in Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia (HABP/VABP) Treated with Imipenem/Cilastatin (IMI)/Relebactam (REL) Versus Piperacillin/Tazobactam (PIP/TAZ)
por: Losada, Maria C, et al.
Publicado: (2020)

1484. Microbial Etiology of Community-acquired Pneumonia in Immunocompromised Patients
por: Deshpande, Abhishek, et al.
Publicado: (2020)

Determinants of Mortality for Ventilated Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia
por: Motowski, Hayley, et al.
Publicado: (2023)

879. Intravenous to Oral Antibiotic Switch in Patients Hospitalized with Community-Acquired Pneumonia
por: Deshpande, Abhishek, et al.
Publicado: (2022)

803. Risk factors associated with Clostridioides difficile infection in hospitalized patients with community-acquired pneumonia
por: Moore, William Justin, et al.
Publicado: (2020)

1498. Etiology of Community-acquired Pneumonia in Adults: A Systematic Review
por: Shoar, Saeed, et al.
Publicado: (2020)

1317. Prevalence of Pseudomonas aeruginosa as the Causative Organism for Community Acquired Pneumonia
por: Haviland, Adam D, et al.
Publicado: (2021)

42. A Pharmacist-Led Intervention to Decrease Anaerobic Coverage for Hospitalized Patients with Community-Acquired Pneumonia
por: Enzmann, Maxx O, et al.
Publicado: (2020)

1514. Mortality and Readmission in Adults during the First Year Following Hospitalization for Community-Acquired Pneumonia in the US
por: Sato, Reiko, et al.
Publicado: (2020)

169. Development of a Real Time Electronic Algorithm to Identify Hospitalized Patients with Community-Acquired Pneumonia
por: Fabre, Valeria, et al.
Publicado: (2020)

1311. Intrapulmonary Pharmacokinetics of Cefiderocol in Hospitalized and Ventilated Patients Receiving Standard of Care Antibiotics for Bacterial Pneumonia
por: Katsube, Takayuki, et al.
Publicado: (2020)

1181. Significant Reduction of Non-Ventilator Hospital-Acquired Pneumonia (HAP) with a Prevention Bundle and Clinical and Leadership Feedback in a Large Integrated Healthcare System
por: Naik, Sejal, et al.
Publicado: (2019)

Effects of systemic steroid in patients with severe community-acquired pneumonia requiring mechanical ventilation
por: Chon, G, et al.
Publicado: (2009)

89. Construction of an Electronic Algorithm to Efficiently Target Antimicrobial Stewardship Efforts for Adults Hospitalized with Community-acquired Pneumonia
por: Lautenbach, Ebbing, et al.
Publicado: (2020)

Non-ventilator associated hospital acquired pneumonia (NV-HAP) risk among hospitalized veterans before and during the COVID-19 pandemic
por: Carey, Evan, et al.
Publicado: (2023)

1267. Nonventilator Hospital Acquired Pneumonia (NV-HAP) Prevention Initiative in Colombia, Bogotá
por: Valderrama, Sandra, et al.
Publicado: (2018)

Author Correction: A 1-minute blood test detects decreased immune function and increased clinical risk in COVID-19 patients
por: Deb, Chirajyoti, et al.
Publicado: (2021)

A 1-minute blood test detects decreased immune function and increased clinical risk in COVID-19 patients
por: Deb, Chirajyoti, et al.
Publicado: (2021)

624. Probability of Target Attainment of Ceftolozane/Tazobactam Among Adult Patients with Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia Secondary to Pseudomonas aeruginosa in Latin America
por: Okuma, Aline, et al.
Publicado: (2022)

Is ventilated hospital-acquired pneumonia a worse entity than ventilator-associated pneumonia?
por: Vallecoccia, Maria Sole, et al.
Publicado: (2020)

Descriptive analysis of ICU patients with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia at four academic medical centers
por: Kett, DH, et al.
Publicado: (2008)

1604. Cost-Effectiveness of Ceftazidime-Avibactam for Patients with Hospital-Acquired Pneumonia Caused by Multi-Drug Resistant Enterobacteriaceae or Pseudomonas in China
por: Furnback, Wesley, et al.
Publicado: (2020)

151. An Electronic Algorithm to Better Target Antimicrobial Stewardship Program (ASP) Efforts for Children Hospitalized with Community-Acquired Pneumonia (CAP)
por: Gerber, Jeffrey, et al.
Publicado: (2020)

1032. Evaluation of a Multiplex Rapid Diagnostic Panel in Respiratory Specimens from Critically Ill Patients with Hospital-Acquired Pneumonia
por: Erich, Bradley J, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dmipbmpmjts0f6dr488ldagnh5